Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2015

Conditions
Hepatitis B, Chronic
Interventions
DRUG

Entecavir

entecavir 0.5 mg QD

DRUG

Lamivudine

lamivudine 100 mg QD

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Severance Hospital

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Konkuk University Hospital

OTHER

collaborator

Chung-Ang University

OTHER

collaborator

Ajou University

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Soonchunhyang University Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Hallym University Medical Center

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Keimyung University

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Korea University

OTHER

collaborator

Hanyang University

OTHER

collaborator

Inje University

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Yonsei University

OTHER

NCT00823550 - Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients | Biotech Hunter | Biotech Hunter